Minister for Health and Wellbeing Meegan Fitzharris MLA, recently announced genomic testing for rare diseases is now available as a routine and publicly funded diagnostic service in the ACT.
Through Canberra Clinical Genomics (CCG) patients battling rare or life-threatening diseases can have their genetic make-up analysed to develop personally tailored treatment and medication plans to manage and treat their conditions.
This advanced diagnostic testing will be available to over 300 Canberrans who need it every year.
CCG is one of only a handful in Australia, to be accredited to provide this whole exome gene sequencing as a diagnostic service.
CCG is an example of how cutting-edge medicine can be achieved by collaboration between health services and university-based research. It is a collaboration between the ACT Health Directorate, Canberra Health Services and the Australian National University, which has benefitted from more than a decade of genomics research at the John Curtin School of Medical Research, and is supported by a $7.3 million investment by the ACT Government.